Compare $FBLG vs $LGVN | Chartloom

Compare

$FBLG vs $LGVN

Fibrobiologics Inc · Longeveron Inc

FBLG

Fibrobiologics Inc

LGVN

Longeveron Inc

Compare $FBLG vs $LGVN

Comparing Fibrobiologics Inc and Longeveron Inc

FBLGFibrobiologics Inc

LGVNLongeveron Inc

FBLGFibrobiologics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.4%

52W performance

-88.8%

FCF yield

-215.4%

LGVNLongeveron Inc

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

64.70x

Rev growth (TTM)

-42.7%

YTD performance

-58.2%

52W performance

-73.3%

FCF yield

-26.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBLG

LGVN

Detailed metrics comparison

FBLG

Fibrobiologics Inc

LGVN

Longeveron Inc

Market Cap

FBLG$7M

LGVN$78M

Enterprise Value

FBLG$3M

LGVN$68M

Price

FBLG$1.13

LGVN$2.48

P/E Ratio

FBLGN/A

LGVNN/A

P/S Ratio

FBLG0.00x

LGVN66.02x

EV/Sales

FBLG0.00x

LGVN57.53x

EV/EBITDA

FBLG0.00x

LGVN0.00x

P/B Ratio

FBLG1.78x

LGVN0.79x

P/FCF Ratio

FBLGN/A

LGVNN/A

EV/FCF

FBLG-0.24x

LGVN-3.30x

PEG Ratio

FBLGN/A

LGVNN/A

Forward P/E (NTM)

FBLGN/A

LGVNN/A

Forward P/S (NTM)

FBLGN/A

LGVN64.70x

Revenue (TTM)

FBLG$0

LGVN$1M

Revenue Growth (YoY)

FBLGN/A

LGVN-42.7%

Forward Rev Growth

FBLG227.6%

LGVN398.7%

Gross Margin (TTM)

FBLG0.0%

LGVN69.8%

Operating Margin (TTM)

FBLG0.0%

LGVN0.0%

EBITDA Margin (TTM)

FBLG0.0%

LGVN-1907.3%

Net Margin (TTM)

FBLG0.0%

LGVN-1977.6%

FCF Margin (TTM)

FBLGN/A

LGVN-1742.1%

Net Income (TTM)

FBLG$-18M

LGVN$-23M

FCF (TTM)

FBLG$-15M

LGVN$-21M

EPS (TTM)

FBLG-$2.89

LGVN-$7.48

ROE (TTM)

FBLG-53678.0%

LGVN-22319.0%

ROA (TTM)

FBLG-22512.0%

LGVN-15020.0%

ROIC (TTM)

FBLG-39304.0%

LGVN-22319.0%

Cash

FBLG$4M

LGVN$10M

Debt

FBLG$124K

LGVN$0

Net Cash/Debt

FBLG$3M

LGVN$10M

Current Ratio (TTM)

FBLG2.64x

LGVN2.63x

Quick Ratio (TTM)

FBLG2.40x

LGVN2.35x

Debt/Equity (TTM)

FBLG0.03x

LGVN0.00x

Debt/Assets (TTM)

FBLG0.0%

LGVN0.0%

Interest Coverage (TTM)

FBLGN/A

LGVNN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

LGVN0.00x

Beta

FBLG1.79

LGVN0.85

52W Performance

FBLG-88.8%

LGVN-73.3%

YTD Performance

FBLG-76.4%

LGVN-58.2%

% from 52W High

FBLG-89.0%

LGVN-79.8%

% from 52W Low

FBLG82.3%

LGVN7.8%

Asset Turnover (TTM)

FBLG0.00x

LGVN0.08x

FCF Yield (TTM)

FBLG-215.4%

LGVN-26.4%

Earnings Yield (TTM)

FBLG-264.0%

LGVN-30.0%

Dividend Yield (TTM)

FBLGN/A

LGVNN/A

Rule of 40

FBLG0.0

LGVN-1,784.9

EV/GP/RG

FBLGN/A

LGVN40.37

Ticker research

View FBLG research View LGVN research

Metric	FBLG Fibrobiologics Inc	LGVN Longeveron Inc
Market & Valuation
Market Cap	$7M	$78M
Enterprise Value	$3M	$68M
Price	$1.13	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	66.02x
EV/Sales	0.00x	57.53x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.78x	0.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-3.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	64.70x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-42.7%
Forward Rev Growth	227.6%	398.7%
Profitability
Gross Margin (TTM)	0.0%	69.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1907.3%
Net Margin (TTM)	0.0%	-1977.6%
FCF Margin (TTM)	N/A	-1742.1%
Net Income (TTM)	$-18M	$-23M
FCF (TTM)	$-15M	$-21M
EPS (TTM)	-$2.89	-$7.48
ROE (TTM)	-53678.0%	-22319.0%
ROA (TTM)	-22512.0%	-15020.0%
ROIC (TTM)	-39304.0%	-22319.0%
Financial Health
Cash	$4M	$10M
Debt	$124K	$0
Net Cash/Debt	$3M	$10M
Current Ratio (TTM)	2.64x	2.63x
Quick Ratio (TTM)	2.40x	2.35x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	0.85
52W Performance	-88.8%	-73.3%
YTD Performance	-76.4%	-58.2%
% from 52W High	-89.0%	-79.8%
% from 52W Low	82.3%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.08x
FCF Yield (TTM)	-215.4%	-26.4%
Earnings Yield (TTM)	-264.0%	-30.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,784.9
EV/GP/RG	N/A	40.37
Ticker research	View FBLG research	View LGVN research

Valuation

P/S Ratio

FBLG

0.00x

LGVN

66.02x

EV/FCF

LGVN

-3.30x

FBLG

-0.24x

Growth & revenue

Revenue Growth TTM

LGVN

-42.7%

Forward Revenue Growth

LGVN

398.7%

FBLG

227.6%

Profitability & performance

Gross Margin

LGVN

69.8%

FBLG

0.0%

ROE

LGVN

-22319.0%

FBLG

-53678.0%

FCF Yield %

LGVN

-26.4%

FBLG

-215.4%

52-Week Performance

LGVN

-73.3%

FBLG

-88.8%

Detailed metrics comparison

FBLG

Fibrobiologics Inc

LGVN

Longeveron Inc

Market Cap

FBLG$7M

LGVN$78M

Enterprise Value

FBLG$3M

LGVN$68M

Price

FBLG$1.13

LGVN$2.48

P/E Ratio

FBLGN/A

LGVNN/A

P/S Ratio

FBLG0.00x

LGVN66.02x

EV/Sales

FBLG0.00x

LGVN57.53x

EV/EBITDA

FBLG0.00x

LGVN0.00x

P/B Ratio

FBLG1.78x

LGVN0.79x

P/FCF Ratio

FBLGN/A

LGVNN/A

EV/FCF

FBLG-0.24x

LGVN-3.30x

PEG Ratio

FBLGN/A

LGVNN/A

Forward P/E (NTM)

FBLGN/A

LGVNN/A

Forward P/S (NTM)

FBLGN/A

LGVN64.70x

Revenue (TTM)

FBLG$0

LGVN$1M

Revenue Growth (YoY)

FBLGN/A

LGVN-42.7%

Forward Rev Growth

FBLG227.6%

LGVN398.7%

Gross Margin (TTM)

FBLG0.0%

LGVN69.8%

Operating Margin (TTM)

FBLG0.0%

LGVN0.0%

EBITDA Margin (TTM)

FBLG0.0%

LGVN-1907.3%

Net Margin (TTM)

FBLG0.0%

LGVN-1977.6%

FCF Margin (TTM)

FBLGN/A

LGVN-1742.1%

Net Income (TTM)

FBLG$-18M

LGVN$-23M

FCF (TTM)

FBLG$-15M

LGVN$-21M

EPS (TTM)

FBLG-$2.89

LGVN-$7.48

ROE (TTM)

FBLG-53678.0%

LGVN-22319.0%

ROA (TTM)

FBLG-22512.0%

LGVN-15020.0%

ROIC (TTM)

FBLG-39304.0%

LGVN-22319.0%

Cash

FBLG$4M

LGVN$10M

Debt

FBLG$124K

LGVN$0

Net Cash/Debt

FBLG$3M

LGVN$10M

Current Ratio (TTM)

FBLG2.64x

LGVN2.63x

Quick Ratio (TTM)

FBLG2.40x

LGVN2.35x

Debt/Equity (TTM)

FBLG0.03x

LGVN0.00x

Debt/Assets (TTM)

FBLG0.0%

LGVN0.0%

Interest Coverage (TTM)

FBLGN/A

LGVNN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

LGVN0.00x

Beta

FBLG1.79

LGVN0.85

52W Performance

FBLG-88.8%

LGVN-73.3%

YTD Performance

FBLG-76.4%

LGVN-58.2%

% from 52W High

FBLG-89.0%

LGVN-79.8%

% from 52W Low

FBLG82.3%

LGVN7.8%

Asset Turnover (TTM)

FBLG0.00x

LGVN0.08x

FCF Yield (TTM)

FBLG-215.4%

LGVN-26.4%

Earnings Yield (TTM)

FBLG-264.0%

LGVN-30.0%

Dividend Yield (TTM)

FBLGN/A

LGVNN/A

Rule of 40

FBLG0.0

LGVN-1,784.9

EV/GP/RG

FBLGN/A

LGVN40.37

Ticker research

View FBLG research View LGVN research

Metric	FBLG Fibrobiologics Inc	LGVN Longeveron Inc
Market & Valuation
Market Cap	$7M	$78M
Enterprise Value	$3M	$68M
Price	$1.13	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	66.02x
EV/Sales	0.00x	57.53x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.78x	0.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-3.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	64.70x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-42.7%
Forward Rev Growth	227.6%	398.7%
Profitability
Gross Margin (TTM)	0.0%	69.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1907.3%
Net Margin (TTM)	0.0%	-1977.6%
FCF Margin (TTM)	N/A	-1742.1%
Net Income (TTM)	$-18M	$-23M
FCF (TTM)	$-15M	$-21M
EPS (TTM)	-$2.89	-$7.48
ROE (TTM)	-53678.0%	-22319.0%
ROA (TTM)	-22512.0%	-15020.0%
ROIC (TTM)	-39304.0%	-22319.0%
Financial Health
Cash	$4M	$10M
Debt	$124K	$0
Net Cash/Debt	$3M	$10M
Current Ratio (TTM)	2.64x	2.63x
Quick Ratio (TTM)	2.40x	2.35x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	0.85
52W Performance	-88.8%	-73.3%
YTD Performance	-76.4%	-58.2%
% from 52W High	-89.0%	-79.8%
% from 52W Low	82.3%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.08x
FCF Yield (TTM)	-215.4%	-26.4%
Earnings Yield (TTM)	-264.0%	-30.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,784.9
EV/GP/RG	N/A	40.37
Ticker research	View FBLG research	View LGVN research